All News
CordenPharma in peptide expansion
Andrew Warmington
SOCMA report finds companies ‘bullish’
Andrew Warmington
Evotec initiates ‘Campus Curie’ in Toulouse
Andrew Warmington
ECHA: REACH driving substitution in many ways
Andrew Warmington
Covid-19: Four more events postponed
Andrew Warmington
Carlyle Group invests in Piramal
Andrew Warmington
Nouryon completes two moves
Andrew Warmington
Clariant continues speciality drive
Andrew Warmington
Cambrex invests in Sweden
Andrew Warmington
Bayer resolves most Monsanto litigation
Andrew Warmington
Solvay to take impairment
Andrew Warmington
ACC: US chemical volumes to slump
Andrew Warmington